Evidence map›Paper›PMID 41408741›Full record

ArticleAnnals of medicine2025

Impact of nonpharmaceutical interventions on inflammatory diseases of the nose.

Lili Dai, Shuhan Liu, Liwei Chen, Xiaofeng Fan, Sirui Wang, Yawen Ding, Xiangwei Yi, Yongran Cheng

Abstract read
In one paragraph

Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lili DaiClinical Medicine Department, Hangzhou Normal University, Hangzhou, People's Republic of China.
Shuhan LiuClinical Medicine Department, Hangzhou Normal University, Hangzhou, People's Republic of China.
Liwei ChenDepartment of Otolaryngology, Langxi County People's Hospital, Xuancheng, People's Republic of China.
Xiaofeng FanClinical Medicine Department, Hangzhou Normal University, Hangzhou, People's Republic of China.
Sirui WangClinical Medicine Department, Hangzhou Normal University, Hangzhou, People's Republic of China.
Yawen DingDepartment of Otolaryngology, Langxi County People's Hospital, Xuancheng, People's Republic of China.
Xiangwei YiDepartment of Otolaryngology, Langxi County People's Hospital, Xuancheng, People's Republic of China.
Yongran ChengSchool of Public Health, Hangzhou Medical College, Hangzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study aimed to investigate the impact of nonpharmaceutical interventions (NPIs), implemented by the Chinese government during 2020-2022 to reduce the spread of coronavirus disease 2019, on the incidence of inflammatory nasal diseases, including chronic nonallergic rhinitis, allergic rhinitis, acute rhinitis, chronic sinusitis and acute sinusitis.

methodsMedical records from the Department of Otorhinolaryngology of the Hangzhou Normal University Affiliated Hospital were analysed to compare the incidence of the five nasal diseases between the pre-pandemic (January 2018-December 2019) and the pandemic prevention periods (January 2020-December 2022). The Chi-square test was used to compare incidence rates and sex/age distributions.

resultsThe incidence of chronic nonallergic rhinitis, chronic sinusitis and acute sinusitis decreased significantly during the pandemic prevention period (

conclusionsNPIs had a significant impact on the incidence and epidemiology of nasal inflammatory diseases, with significant differences in incidence rate, sex and age distribution between the pre-pandemic and pandemic prevention periods.

Indexed as

COVID-19RhinitisSinusitisAdolescentAdultAgedChildChinaChronic DiseaseFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesRhinitis, AllergicCOVID-19masksotolaryngologypandemicsrhinitisrhinosinusitis

Identifiers

PMID41408741
PMCPMC12716473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.